JTEC Toekomstige groei

Future criteriumcontroles 5/6

JTEC is forecast to grow earnings and revenue by 33.7% and 20.8% per annum respectively. EPS is expected to grow by 33.8% per annum. Return on equity is forecast to be 14.7% in 3 years.

Belangrijke informatie

33.7%

Groei van de winst

33.8%

Groei van de winst per aandeel

Medical Equipment winstgroei13.7%
Inkomstengroei20.8%
Toekomstig rendement op eigen vermogen14.7%
Dekking van analisten

Low

Laatst bijgewerkt27 Aug 2024

Recente toekomstige groei-updates

Recent updates

Health Check: How Prudently Does JTEC (TSE:3446) Use Debt?

Aug 02
Health Check: How Prudently Does JTEC (TSE:3446) Use Debt?

Winst- en omzetgroeiprognoses

TSE:3446 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (JPY Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
6/30/20273,9106509601,1101
6/30/20263,2905205406701
6/30/20252,7703904105201
6/30/20242,010199-8062N/A
3/31/20241,602-10N/AN/AN/A
12/31/20231,920177256322N/A
9/30/20231,975247N/AN/AN/A
6/30/20231,908238128210N/A
3/31/20231,554105N/AN/AN/A
12/31/20221,33640-39130N/A
9/30/20221,33721N/AN/AN/A
6/30/20221,150-32171284N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: 3446's forecast earnings growth (33.7% per year) is above the savings rate (0.3%).

Winst versus markt: 3446's earnings (33.7% per year) are forecast to grow faster than the JP market (8.9% per year).

Hoge groeiwinsten: 3446's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: 3446's revenue (20.8% per year) is forecast to grow faster than the JP market (4.2% per year).

Hoge groei-inkomsten: 3446's revenue (20.8% per year) is forecast to grow faster than 20% per year.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: 3446's Return on Equity is forecast to be low in 3 years time (14.7%).


Ontdek groeibedrijven